E-learning PCSK9i & LDL-c: Guidelines, Practice and Innovation
This educational program consists of three presentations on PCSK9 inhibition and LDL-c.
This course consists of the following:
- One year after the new ESC/EAS dyslipidemia guidelines - Prof. François Mach, MD – Geneva, Switzerland
- Five years of PCSK9i – Lessons from practice: Which patients benefit most? - Prof. Erik Stroes, MD – Amsterdam, The Netherlands
- Time to reduce implementation gaps of lipid-lowering therapy - Prof. Kausik Ray, MD – London, UK
After watching these three videos, the learner should be able to:
- Describe the most important changes in the 2019 ESC/EAS dyslipidemia guidelines
- Identify lessons learned from real-world studies with PCSK9i
- Recall which patients benefit most from PCSK9i therapy
- Describe the current prevalence of use of different lipid lowering therapies in the EU
- Describe use of statins shown in the PURE study
- Identify how 2019 LDL-c goals can be achieved in most high-risk patients
- Prof. François Mach, MD - Head of the Cardiology Division, Geneva University Hospital, Geneva, Switzerland, and Professor of Cardiology, Geneva University Medical School, Geneva, Switzerland.
- Prof. Erik Stroes is Professor of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- Prof. Kausik Ray is a cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom.
This educational activity is designed for cardiologists in secondary care and other healthcare professionals with an interest in LDL-c lowering.
This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit.
Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.
Funding for this educational program was provided by an unrestricted educational grant from Sanofi and Amgen.
This is available as accredited online CME for members. Click the button below to enroll:Enroll